CRL vs TASK · rev $4.05B vs P/E 4.8, rev $995.0M
Charles River Laboratories (CRL) versus Taskus Inc (TASK) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Latest reported CRL revenue for 2024-12-28 was $4.05B. Net income was $25.3M. Revenue was down 1.9% from 2023-12-30 to 2024-12-28. CRL currently screens at market cap $7.78B.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
CRL currently screens at market cap $7.78B. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Not investment advice. Open the CRL and TASK stock pages for the full models.
Not investment advice.